Reprogramming of PD-1+ M2-like tumor-associated macrophages with anti-PD-L1 and lenalidomide in cutaneous T cell lymphoma.
- DOI
- 10.1172/jci.insight.163518
- Published
- 2023 Jul 10
- Container
- JCI insight
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1172/jci.insight.163518,
title = {Reprogramming of PD-1+ M2-like tumor-associated macrophages with anti-PD-L1 and lenalidomide in cutaneous T cell lymphoma.},
author = {Han Z and Wu X and Qin H and Yuan YC and Schmolze D and Su C and Zain J and Moyal L and Hodak E and Sanchez JF and Lee PP and Feng M and Rosen ST and Querfeld C},
year = {2023},
journal = {JCI insight},
doi = {10.1172/jci.insight.163518},
url = {https://doi.org/10.1172/jci.insight.163518}
}RIS
TY - JOUR TI - Reprogramming of PD-1+ M2-like tumor-associated macrophages with anti-PD-L1 and lenalidomide in cutaneous T cell lymphoma. AU - Han Z AU - Wu X AU - Qin H AU - Yuan YC AU - Schmolze D AU - Su C AU - Zain J AU - Moyal L AU - Hodak E AU - Sanchez JF AU - Lee PP AU - Feng M AU - Rosen ST AU - Querfeld C PY - 2023 JO - JCI insight DO - 10.1172/jci.insight.163518 UR - https://doi.org/10.1172/jci.insight.163518 ER -
APA
Z, H., X, W., H, Q., YC, Y., D, S., C, S., J, Z., L, M., E, H., JF, S., PP, L., M, F., ST, R., & C, Q. (2023). Reprogramming of PD-1+ M2-like tumor-associated macrophages with anti-PD-L1 and lenalidomide in cutaneous T cell lymphoma.. JCI insight. https://doi.org/10.1172/jci.insight.163518
Source records
- pubmed · retrieved 2026-09-26T19:16:01.674Z